Einfuhrung in die physiologishe embryologie /

Por Lehmann, F. E.
Publicado em c194

The myth of test tube embryos.

Por Lehmann, F. M.
Publicado em 1986

Theory of Cancer Treatment

Por Lehmann, F. M.
Publicado em 1952

Nature Cure

Por Lehmann, F. M.
Publicado em 1952

Cancer Treatment

Por Lehmann, F. M.
Publicado em 1952

Carcinoma of the Breast

Por Lehmann, F. M.
Publicado em 1958

Crooked Thinking in Medicine

Por Lehmann, F. M.
Publicado em 1954

The Case for Rational Surgery in Cancer

Por Lehmann, F. M.
Publicado em 1955

Geografia del Japon /

Por Lehmann, F. W. Paul.
Publicado em 1929

Cost of German Medical Journals

Por Schroeder, Hermann, Lehmann, F.
Publicado em 1933

Letter: Serum alpha-fetoprotein in cystic fibrosis.

Por Knopple, G, Rotthauwe, H W, Lehmann, F G
Publicado em 1975

Iron deficiency anemia in 1-year-old children of disadvantaged families in Montreal.

Por Lehmann, F, Gray-Donald, K, Mongeon, M, Di Tommaso, S
Publicado em 1992

A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma.

Por Coulie, P G, Lehmann, F, Lethé, B, Herman, J, Lurquin, C, Andrawiss, M, Boon, T
Publicado em 1995

Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist

Por Hildebrand, P, Lehmann, F, Ketterer, S, Christ, A, Stingelin, T, Beltinger, J, Gibbons, A, Coy, D, Calam, J, Larsen, F, Beglinger, C
Publicado em 2001

The novel tyrosine kinase inhibitor AKN-028 has significant antileukemic activity in cell lines and primary cultures of acute myeloid leukemia

Por Eriksson, A, Hermanson, M, Wickström, M, Lindhagen, E, Ekholm, C, Jenmalm Jensen, A, Löthgren, A, Lehmann, F, Larsson, R, Parrow, V, Höglund, M
Publicado em 2012

Phosphorylation-dependent power output of transgenic flies: an integrated study.

Por Dickinson, M H, Hyatt, C J, Lehmann, F O, Moore, J R, Reedy, M C, Simcox, A, Tohtong, R, Vigoreaux, J O, Yamashita, H, Maughan, D W
Publicado em 1997

Safety and immunogenicity of neoadjuvant treatment using WT1-immunotherapeutic in combination with standard therapy in patients with WT1-positive Stage II/III breast cancer: a rand...

Por Higgins, M., Curigliano, G., Dieras, V., Kuemmel, S., Kunz, G., Fasching, P. A., Campone, M., Bachelot, T., Krivorotko, P., Chan, S., Ferro, A., Schwartzberg, L., Gillet, M., De Sousa Alves, P. M., Wascotte, V., Lehmann, F. F., Goss, P.
Publicado no Breast Cancer Res Treat (2017)

Safety and immunogenicity of the PRAME cancer immunotherapeutic in metastatic melanoma: results of a phase I dose escalation study

Por Gutzmer, R, Rivoltini, L, Levchenko, E, Testori, A, Utikal, J, Ascierto, P A, Demidov, L, Grob, J J, Ridolfi, R, Schadendorf, D, Queirolo, P, Santoro, A, Loquai, C, Dreno, B, Hauschild, A, Schultz, E, Lesimple, T P, Vanhoutte, N, Salaun, B, Gillet, M, Jarnjak, S, De Sousa Alves, P M, Louahed, J, Brichard, V G, Lehmann, F F
Publicado no ESMO Open (2016)